Image-guided Therapy Systems Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033

The Image-guided Therapy Systems Market is expected to reach US$ 8.42 billion by 2033 from US$ 4.96 billion in 2024, with a CAGR of 6.05% from 2025 to 2033. The main factors supporting the market share are the introduction of advantageous regulations by governmental organizations to reduce the amount of carbon emissions emitted by automobiles and the advancement of electric bicycles.

Global Image-guided Therapy Systems Industry Overview

Systems for image-guided treatment (IGT) are used to plan, carry out, and assess therapeutic and surgical operations. They let medical personnel treat patients in real time, which reduces the need for repeat treatments and shortens hospital stays. Additionally, they provide integrated solutions for sophisticated MIS. Computed tomography (CT) and magnetic resonance imaging (MRI) are two of the IGT systems' frequently used modalities. For improved patient outcomes, these modalities are supplemented by surgical navigation equipment, integrated software, tracking tools, angiography, and ultrasound.

One of the main factors driving the growth of the worldwide IGT systems market is the increasing number of people receiving a cancer diagnosis. The growing demand for MI treatments and the growing use of smart medical devices and contemporary clinical procedures to get pertinent information at the point of care (POC) are also driving market expansion. The major players are now launching various IGT system techniques that treat internal organs and tissues without requiring a surgical incision by using imaging and specialized tools. The demand for IGT systems is rising globally as a result of these systems' contributions to better patient outcomes, less strain on the healthcare system, and the advancement of precision medicine. The market's expansion is being reinforced by the aging population and the associated chronic illnesses. In addition, it is expected that increased cooperation among healthcare organizations would improve the efficacy of therapeutic interventions and have a favorable impact on the market.

The market expansion is also being favorably impacted by the rising number of efforts for cancer radiation and the growing burden of chronic diseases like cancer. For example, the American Cancer Society estimates that 9.7 million people died from cancer worldwide in 2022, while around 20 million new cases were diagnosed. Due to population expansion, it is anticipated that the number of cases would increase to 35 million by 2050. 49% of new cases were in Asia, with 24% occurring in China alone.

Growth Drivers for the Image-guided Therapy Systems Market

Advancements in Imaging Technologies

The accuracy and usefulness of image-guided therapeutic systems have been greatly improved by the ongoing development of imaging technologies like MRI, CT, and ultrasound. Clinicians can now more clearly see interior structures thanks to these developments, which makes it possible to plan and carry out difficult surgeries more precisely. These capabilities are further enhanced by the combination of artificial intelligence (AI) and machine learning (ML), which makes it easier to do automatic picture interpretation, predictive diagnoses, and real-time data analysis. These developments increase the consistency of results and lessen human error. Additionally, AI-powered imaging systems aid in decision-making throughout operations, improving the efficacy and efficiency of surgery. Image-guided treatments are being increasingly widely used in a variety of therapeutic specialties as imaging technology advance and become more widely available.

Rising Prevalence of Chronic Diseases

The need for cutting-edge treatment solutions is rising as a result of the global increase in chronic diseases including cancer, heart disease, and neurological disorders. To enhance prognosis and reduce complications, these disorders frequently need for precise and focused therapies. Because image-guided treatment systems provide precise real-time imaging and localization of diseased regions, they are particularly positioned to address this need. These methods enhance patient outcomes and shorten recovery periods by increasing treatment precision and lowering the possibility of collateral injury to healthy tissues. Healthcare professionals are increasingly using image-guided treatments to address the demand for efficient, individualized, and less invasive treatment alternatives as the burden of chronic diseases keeps rising.

Preference for Minimally Invasive Procedures

Due to its many advantages, such as shorter hospital stays, faster recovery periods, less postoperative discomfort, and a lower risk of infection, minimally invasive operations, or MIS, are becoming more and more common. By giving surgeons high-resolution, real-time images of the surgical site, image-guided treatment systems are essential in making these operations easier. This guiding improves safety and efficacy by enabling accurate navigation and intervention, even in anatomically difficult locations. These technologies are particularly useful for operations like neurosurgery and interventional cardiology that need tiny incisions or fragile structures. The use of image-guided technologies is increasing in tandem with patient desire for less intrusive treatment choices, contributing to a larger trend toward minimally invasive and patient-centered surgical care.

Challenges in the Image-guided Therapy Systems Market

Complex Integration with Existing Infrastructure

It can be difficult and resource-intensive to integrate image-guided treatment systems into the hospital's current infrastructure. Electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and operating rooms must all be smoothly integrated with these technologies. Healthcare institutions sometimes use antiquated or incompatible platforms, which makes integration difficult and expensive. Clinical workflows might be interrupted, delays can occur, and data fragmentation can result from poor device and software compatibility. The operational strain is further increased by the requirement for regular system upgrades and specialist IT assistance. Image-guided treatment systems can't reach their full potential without seamless integration, and their operational and therapeutic advantages might be greatly reduced.

Radiation Exposure Concerns

Ionizing radiation-based imaging modalities including computed tomography (CT) and fluoroscopy are used in many image-guided treatment procedures. Although the high-resolution imaging provided by these technologies is essential for precise surgery, prolonged or repeated exposure poses serious health concerns to patients and medical personnel. An elevated risk of cancer and other radiation-induced diseases has been linked to prolonged radiation exposure. Strict safety procedures, including as shielding, dosage monitoring, and exposure duration limitation, must thus be adhered to. Despite being necessary, these measures can make operations more difficult and complicated. Manufacturers are being forced to create lower-dose imaging technologies due to increased regulatory scrutiny over radiation safety, yet acceptance of these advancements can be expensive and difficult.

United States Image-guided Therapy Systems Market

The market for image-guided treatment systems in the US is expanding quickly because to a strong healthcare system, growing demand for less invasive procedures, and technology breakthroughs. To improve the accuracy, safety, and results of difficult operations in specialties like neurosurgery, cardiology, and cancer, hospitals and surgical centers are progressively using these systems. Accurate targeting and treatment are supported by the combination of real-time navigation technologies with sophisticated imaging modalities such as MRI, CT, and ultrasound. Additionally, the advantages of image-guided therapy are becoming more widely recognized among patients and doctors, which is driving market adoption. The United States continues to be in the forefront of research and implementation in this sector, despite obstacles such high equipment prices and integration difficulties.

Germany Image-guided Therapy Systems Market

The market for image-guided treatment systems in Germany is expanding steadily due to the country's strong research environment, extensive healthcare system, and rising desire for less invasive procedures. The nation is leading the way in implementing cutting-edge imaging techniques like endoscopy, MRI, and CT, which are essential to many surgical specialties, including cardiology, oncology, and neurosurgery. Germany's strategic location in Europe makes it easier to work with other nations and promotes the sharing of cutting-edge methods and technology. This setting promotes the creation and uptake of image-guided therapeutic systems, improving procedure results and patient care. Germany continues to dominate the industry despite obstacles like expensive equipment and difficult integration, with major businesses like Siemens Healthineers and Brainlab advancing the sector.

Japan Image-guided Therapy Systems Market

The market for image-guided therapeutic systems in Japan is expanding steadily due to the nation's sophisticated healthcare system, high rates of medical technology adoption, and emphasis on precision medicine. The accuracy and safety of several minimally invasive operations in fields like neurosurgery, cardiology, and cancer have increased because to the combination of state-of-the-art imaging modalities like MRI, CT, and ultrasound with real-time navigation systems. The need for this technology is further increased by Japan's aging population, as elderly patients frequently need sophisticated therapies. Furthermore, the nation's dedication to R&D encourages medical imaging innovation, which supports the ongoing development of image-guided therapeutic systems.

Saudi Arabia Image-guided Therapy Systems Market

The market for image-guided therapeutic systems in Saudi Arabia is expanding steadily due to improvements in healthcare infrastructure and medical technology. Advanced imaging modalities including MRI, CT, and ultrasound are being more widely used as a result of the Kingdom's Vision 2030 plan, which places a strong emphasis on modernizing healthcare services. Because they allow for accurate diagnosis and less invasive operations, these technologies are essential to many surgical disciplines, such as cardiology, neurosurgery, and oncology. The need for image-guided therapy is further fueled by the aging population and the increasing frequency of chronic illnesses. Additionally, investments in medical research and partnerships with international healthcare providers support the creation and application of state-of-the-art imaging technologies. Saudi Arabia is establishing itself as a pioneer in the Middle East's adoption of image-guided therapeutic systems, despite obstacles including the high cost of the technology and the requirement for specialized training.

Recent Developments in Image-guided Therapy Systems Industry

• The innovative Azurion image-guided treatment device from Philips India was added to intervention lists in a number of disciplines in November 2024. The system's improved imaging capabilities and optimized workflows are intended to improve the results of therapy for neurovascular and cardiovascular conditions. Features of the Azurion include AI-powered remote monitoring for proactive servicing, extensive table-side control, and quick switching between 2D and 3D imaging. The technology, which is on display at the Philips Innovation Campus in Bengaluru, attempts to save expenses while improving patient care, accuracy, and efficiency.
• Philips and Medtronic Neurovascular formed a strategic alliance in October 2024 to provide better access to prompt stroke care. The partnership seeks to increase stroke detection and treatment by increasing awareness, expanding access to treatment, and utilizing technology, such as image-guided therapy devices. In order to alleviate the worldwide burden of stroke, both businesses have additionally bolstered their collaboration with the World Stroke Organization by joining the WSO Advocacy Coalition.

Image-guided Therapy Systems Market Segmentation

Product

• Endoscope
• Magnetic Resonance Imaging
• Computed Tomography Scanners
• Ultrasound Systems
• X-Rat Fluoroscopy
• Single Photon Emission Computed Tomography
• Positron Emission Tomography

Application

• Cardiac Surgery
• Neurosurgery
• Orthopedic Surgery
• Urology
• Gastroenterology
• Oncology Surgery
• Others

End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research & Academic Institutions

Country

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

The key players have been analyzed by:

• Overview
• Key Persons
• Recent Development & Strategies
• Revenue Analysis

Key Players Analyzed:

• Siemens Healthineers
• Koninklijke Philips
• General Electric Company
• Brainlab
• Medtronic Plc
• Olympus Corporation
• KARL STORZ SE & Co. KG
• Stryker Corporation